Transient expression of herpes simplex virus type 1 ICP22 represses viral promoter activity and complements the replication of an ICP22 null virus

Journal of Virology

Volumn 83, Issue 17, 2009, Pages 8733-8743

  Bowman, J Jason ^a,c   Orlando, Joseph S ^a,d   Davido, David J ^a,e   Kushnir, Anna S ^a,f   Schaffer, Priscilla A ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b The University of Arizona   (United States)

^c Karp Family Research Building ^*  (United States)

^d MILLIPORE CORPORATION   (United States)

^e UNIVERSITY OF KANSAS   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; IMMEDIATE EARLY PROTEIN; INFECTED CELL PROTEIN 0; INFECTED CELL PROTEIN 22; NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; ICP22 PROTEIN, HUMAN HERPESVIRUS 1; UBIQUITIN PROTEIN LIGASE; VMW110 PROTEIN, HUMAN HERPESVIRUS 1;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE ACTIVITY; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS 1; INHIBITION KINETICS; NONHUMAN; NULL VIRUS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; TRANSACTIVATION; TRANSIENT EXPRESSION; VIRUS; VIRUS EXPRESSION; VIRUS GENOME; VIRUS MUTANT; VIRUS REPLICATION; WILD TYPE; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC COMPLEMENTATION; GENETICS; PHYSIOLOGY;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 1;

GENE DELETION; GENE EXPRESSION REGULATION, VIRAL; GENETIC COMPLEMENTATION TEST; HERPESVIRUS 1, HUMAN; IMMEDIATE-EARLY PROTEINS; PROMOTER REGIONS, GENETIC; UBIQUITIN-PROTEIN LIGASES; VIRUS REPLICATION;

EID: 69249222750     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00810-09     Document Type: Article

References (18)

1. Balliet, J. W., J. C. Min, M. S. Cabatingan, and P. A. Schaffer. 2005. Site-directed mutagenesis of large DNA palindromes: construction and in vitro characterization of herpes simplex virus type 1 mutants containing point mutations that eliminate the oriL or oriS initiation function. J. Virol. 79: 12783-12797.
2. Cun, W., M. Hong, L. D. Liu, C. H. Dong, J. Luo, and Q. H. Li. 2006. Structural and functional characterization of herpes simplex virus 1 immediate-early protein infected-cell protein 22. J. Biochem. 140:67-73.
3. Davido, D. J., and D. A. Leib. 1998. Analysis of the basal and inducible activities of the ICPO promoter of herpes simplex virus type 1. J. Gen. Virol. 79:2093-2098.
4. Fraser, K. A., and S. A. Rice. 2007. Herpes simplex virus immediate-early protein ICP22 triggers loss of serine 2-phosphorylated RNA polymerase II. J. Virol. 81:5091-5101.
5. Kwun, H. J., S. W. Yim, D. H. Lee, and K. L. Jang. 1999. Activation of the thymidine kinase promoter by herpes simplex virus type 1 immediate early proteins. Mol. Cells 9:277-280. (Pubitemid 129555792)
6. 134.5 transcripts and latency-associated transcripts. J. Virol. 72:4250-4264.
7. Long, M. C., V. Leong, P. A. Schaffer, C. A. Spencer, and S. A. Rice. 1999. ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II. J. Virol. 73:5593-5604.
8. S1.5 genes downregulate levels of S-phase-specific cyclins and facilitate virus replication in S-phase Vero cells. J. Virol. 80:4005-4016.
9. Orlando, J. S., J. W. Balliet, A. S. Kushnir, T. L. Astor, M. Kosz-Vnenchak, S. A. Rice, D. M. Knipe, and P. A. Schaffer. 2006. ICP22 is required for wild-type composition and infectivity of herpes simplex virus type 1 virions. J. Virol. 80:9381-9390.
10. Poffenberger, K. L., A. D. Idowu, E. B. Fraser-Smith, P. E. Raichlen, and R. C. Herman. 1994. A herpes simplex virus type 1 ICP22 deletion mutant is altered for virulence and latency in vivo. Arch. Virol. 139:111-119.
11. Poffenberger, K. L., P. E. Raichlen, and R. C. Herman. 1993. In vitro characterization of a herpes simplex virus type 1 ICP22 deletion mutant. Virus Genes 7:171-186.
12. Post, L. E., and B. Roizman. 1981. A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth. Cell 25:227-232.
13. Prod'hon, C., I. Machuca, H. Berthomme, A. Epstein, and B. Jacquemont. 1996. Characterization of regulatory functions of the HSV-1 immediate-early protein ICP22. Virology 226:393-402.
14. Purves, F. C., W. O. Ogle, and B. Roizman. 1993. Processing of the herpes simplex virus regulatory protein alpha 22 mediated by the UL13 protein kinase determines the accumulation of a subset of alpha and gamma mRNAs and proteins in infected cells. Proc. Natl. Acad. Sci. USA 90:6701-6705.
15. Rice, S. A., M. C. Long, V. Lam, P. A. Schaffer, and C. A. Spencer. 1995. Herpes simplex virus immediate-early protein ICP22 is required for viral modification of host RNA polymerase II and establishment of the normal viral transcription program. J. Virol. 69:5550-5559.
16. Sears, A. E., I. W. Halliburton, B. Meignier, S. Silver, and B. Roizman. 1985. Herpes simplex virus 1 mutant deleted in the alpha 22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice. J. Virol. 55:338-346.
17. Sears, A. E., B. Meignier, and B. Roizman. 1985. Establishment of latency in mice by herpes simplex virus 1 recombinants that carry insertions affecting regulation of the thymidine kinase gene. J. Virol. 55:410-416.
18. Stelz, G., E. Rucker, O. Rosorius, G. Meyer, R. H. Stauber, M. Spatz, M. M. Eibl, and J. Hauber. 2002. Identification of two nuclear import signals in the alpha-gene product ICP22 of herpes simplex virus 1. Virology 295:360-370. (Pubitemid 34921322)